Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P43403: Variant p.Leu337Arg

Tyrosine-protein kinase ZAP-70
Gene: ZAP70
Feedback?
Variant information Variant position: help 337 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Leucine (L) to Arginine (R) at position 337 (L337R, p.Leu337Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (L) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In IMD48. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 337 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 619 The length of the canonical sequence.
Location on the sequence: help SPYSDPEELKDKKLFLKRDN L LIADIELGCGNFGSVRQGVY The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         SPYSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVY

Mouse                         SPYSDPEELKDKKLFLKRENLLVADIELGCGNFGSVRQGVY

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 619 Tyrosine-protein kinase ZAP-70
Region 255 – 337 Interdomain B
Modified residue 319 – 319 Phosphotyrosine
Mutagenesis 319 – 319 Y -> A. Increased constitutive kinase activity; when associated with F-315.
Mutagenesis 319 – 319 Y -> F. Increased constitutive kinase activity; when associated with F-315. About 80% loss of TCR-induced NFAT activation.
Mutagenesis 327 – 327 D -> P. Increases constitutive kinase activity on LAT phosphorylation, strongly increases subcellular localization of CD69 at the cell surface and decreases autoinhibition conformation.
Beta strand 337 – 345



Literature citations
Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency.
Turul T.; Tezcan I.; Artac H.; de Bruin-Versteeg S.; Barendregt B.H.; Reisli I.; Sanal O.; van Dongen J.J.; van der Burg M.;
Eur. J. Pediatr. 168:87-93(2009)
Cited for: VARIANTS IMD48 ARG-337; VAL-507 AND ARG-564;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.